RAZA SAIYED ATIQ sold $3.2M of AIP (indirect holdings)
RAZA SAIYED ATIQ sold 70,000 indirectly-held shares of Arteris, Inc. (AIP) at an average of $45.39 ($43.98–$47.10, $3.18M total) across 4 trades on 2026-07-01 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The only new information is the disclosed open-market sale size, price range, and that it was executed under a 10b5-1 plan. No new company fundamentals are provided.
Market read
Traders may note insider selling, but the 10b5-1 structure reduces interpretive weight versus an unplanned sale.
What to watch
The article does not state whether the director increased other holdings, sold for tax/estate reasons, or whether there were concurrent insider purchases, so the net insider signal is incomplete.
Background
The article is an SEC Form 4 insider transaction disclosure for Arteris, Inc. (AIP).
Ticker impact
Arteris director RAZA SAIYED ATIQ sold about 70,000 shares in open-market trades under a 10b5-1 plan, totaling $3.18M.
Low near-term impact; any reaction is likely limited to short-lived sentiment around insider selling.
The filing is a Form 4 insider transaction with explicit 10b5-1 pre-arrangement, and it does not include new operational, financial, or regulatory information about Arteris.
Market effects
Minimal. Insider selling at a single small/mid-cap biotech/med-tech name typically does not reset sector expectations.
None indicated.
None indicated.
Counterpoint
Because the trades were executed under a pre-arranged 10b5-1 plan, the sale may reflect liquidity planning rather than bearish views, limiting signal quality.
Key entities
- issuerArteris, Inc.
Company whose director executed pre-arranged insider sales disclosed on Form 4.
- insiderRAZA SAIYED ATIQ
Director who sold 70,000 shares across four trades on 2026-07-01.
